A detailed history of Federated Hermes, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Federated Hermes, Inc. holds 449,973 shares of DHR stock, worth $105 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
449,973
Previous 469,140 4.09%
Holding current value
$105 Million
Previous $117 Million 6.72%
% of portfolio
0.29%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$239.25 - $280.76 $4.59 Million - $5.38 Million
-19,167 Reduced 4.09%
449,973 $125 Million
Q2 2024

Aug 08, 2024

SELL
$235.51 - $267.98 $11.3 Million - $12.9 Million
-48,016 Reduced 9.28%
469,140 $117 Million
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $18 Million - $20.5 Million
-80,212 Reduced 13.43%
517,156 $129 Million
Q4 2023

Jan 31, 2024

SELL
$185.1 - $233.13 $6.28 Million - $7.91 Million
-33,927 Reduced 5.37%
597,368 $138 Million
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $16.1 Million - $18.4 Million
-69,142 Reduced 9.87%
631,295 $157 Million
Q2 2023

Aug 14, 2023

SELL
$224.99 - $256.14 $6.14 Million - $6.99 Million
-27,294 Reduced 3.75%
700,437 $168 Million
Q1 2023

May 08, 2023

SELL
$239.75 - $277.0 $8.81 Million - $10.2 Million
-36,760 Reduced 4.81%
727,731 $183 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $16.1 Million - $18.8 Million
66,631 Added 9.55%
764,491 $203 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $3.89 Million - $23.7 Million
-15,727 Reduced 2.2%
697,860 $180 Million
Q2 2022

Aug 15, 2022

SELL
$237.11 - $299.66 $1.99 Million - $2.51 Million
-8,378 Reduced 1.16%
713,587 $181 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $1.63 Million - $1.99 Million
-6,318 Reduced 0.87%
721,965 $212 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $698,071 - $786,333
-2,390 Reduced 0.33%
728,283 $240 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $200,074 - $244,336
-735 Reduced 0.1%
730,673 $222 Million
Q2 2021

Aug 16, 2021

SELL
$225.08 - $271.69 $2.05 Million - $2.47 Million
-9,086 Reduced 1.23%
731,408 $196 Million
Q1 2021

May 13, 2021

BUY
$212.38 - $245.9 $13.4 Million - $15.5 Million
62,868 Added 9.28%
740,494 $167 Million
Q4 2020

Feb 12, 2021

BUY
$212.5 - $245.46 $46 Million - $53.1 Million
216,379 Added 46.91%
677,626 $151 Million
Q3 2020

Nov 12, 2020

SELL
$177.16 - $215.33 $4.78 Million - $5.82 Million
-27,009 Reduced 5.53%
461,247 $99.3 Million
Q2 2020

Aug 13, 2020

BUY
$128.7 - $176.83 $11.2 Million - $15.4 Million
87,093 Added 21.71%
488,256 $86.3 Million
Q1 2020

May 13, 2020

SELL
$121.39 - $169.05 $13.1 Million - $18.3 Million
-108,133 Reduced 21.23%
401,163 $55.5 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $9.08 Million - $10.4 Million
68,018 Added 15.41%
509,296 $78.2 Million
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $3.04 Million - $3.29 Million
-22,464 Reduced 4.84%
441,278 $63.7 Million
Q2 2019

Aug 14, 2019

SELL
$124.88 - $143.73 $738,914 - $850,450
-5,917 Reduced 1.26%
463,742 $66.3 Million
Q1 2019

May 10, 2019

SELL
$97.62 - $132.29 $7.19 Million - $9.74 Million
-73,633 Reduced 13.55%
469,659 $62 Million
Q4 2018

Feb 13, 2019

SELL
$94.85 - $109.54 $1.98 Million - $2.29 Million
-20,922 Reduced 3.71%
543,292 $56 Million
Q3 2018

Nov 13, 2018

SELL
$98.13 - $108.9 $5.68 Million - $6.3 Million
-57,890 Reduced 9.31%
564,214 $61.3 Million
Q2 2018

Aug 10, 2018

SELL
$96.1 - $103.24 $7.83 Million - $8.42 Million
-81,514 Reduced 11.58%
622,104 $61.4 Million
Q1 2018

May 09, 2018

SELL
$92.16 - $103.8 $59.8 Million - $67.4 Million
-649,345 Reduced 47.99%
703,618 $68.9 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $16.6 Million - $18.5 Million
195,092 Added 16.85%
1,352,963 $0
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $91.8 Million - $102 Million
1,157,871
1,157,871 $99.3 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.